High Quality Diclofenac Tablet, Rheumatoid Arthritis, Paracetamol Tablet Suppliers in China

Home > Products > Antipyretic & Analgesic Drug > Amikacin Injection General Medicine Drugs

Amikacin Injection General Medicine Drugs

Basic Info

Model No.:  S15D371

Product Description

Model NO.: S15D371 Usage Mode: For oral administration State: Solid Type: Organic Chemicals Name: Amikacin Sulfate Injection Composition: Beta-Lactam Package: 1 Vial/Box Size: *** Storage: Below 30 Degree Trademark: DAWA HS Code: 3004909090 Application: Internal Medicine Suitable for: Elderly, Children, Adult Shape: Tablet Pharmaceutical Technology: Chemical Synthesis Color: Pure Specification: 100mg/2ml, 500mg/2ml, 100mg/2ml Category: Health Care Use: Intramuscular Caution: Consult Your Doctor Origin: China Amikacin Sulfate Injection Hospital-acquired Treating

Specification Package
100mg/2ml 1vial/box
500mg/2ml 1vial/box
Amikacin Injection General Medicine Drugs
Amikacin, sold under the brandname Amikin, is an aminoglycoside antibiotic used to treat different types of bacterial infections. Amikacin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.

Amikacin was initially sold in 1976. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.

Amikacin is most often used for treating severe, hospital-acquired infections with multidrug-resistant Gram-negative bacteria such as Pseudomonas aeruginosa, Acinetobacter, and Enterobacter. Serratia marcescens and Providencia stuartii are also included in the spectrum. Amikacin can also be used to treat non-tubercular mycobacterial infections and tuberculosis (if caused by sensitive strains) when first-line drugs fail to control the infection.

Amikacin may be combined with a beta-lactam antibiotic for empiric therapy for people with neutropenia and fever.

Liposomal amikacin for inhalation is currently in late stage clinical trials for the treatment of respiratory diseases, such as cystic fibrosis, Pseudomonas aeruginosa, non-tubercular mycobacterial infections and bronchiectasis.

Contact us if you need more details on Amikacin. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Medicine、Hospital. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Antipyretic & Analgesic Drug